Abstract Details

Title Impact of NEOD001 on Neuropathy in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction: Results From the Expansion Phase of a Phase 1/2 Study

Topic General Neurology

Presentation(s) S5 - (-)

Poster/Presentation
Number 001

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Gene G. Kinney, PhD (Janssen Alzheimer Immunotherapy)	No disclosure on file
Martin Koller, MD, MPH	No disclosure on file
Dale Schenk, PhD (Elan Pharmaceuticals)	No disclosure on file
	No disclosure on file
Enchi Liu, PhD (JANSSEN Alzheimer Immunotherapy)	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��